EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacogenomic augmented machine learning in electronic health record alerts: A health system‐wide usability survey of clinicians

Caroline W Grant iD, Jean Marrero-Polanco iD, Jeremiah B Joyce iD, Barbara Barry iD, Ashley Stillwell iD, Kellie Kruger, Therese Anderson iD, Heather Talley, Mary Hedges iD, Jose Valery iD, Richard White iD, Richard R Sharp iD und 4 weitere

Clinical and Translational Science · 2024

DOI: 10.1111/cts.70044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Caroline W Grant und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Electronic Health Records, Machine Learning, Citalopram, Pharmacogenetics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science Foundation, National Institutes of Health Predoctoral T32 Fellowship, Harry C. and Debra A. Stonecipher Predoctoral Fellowship (CWG) at the Mayo Clinic Graduate School of Biomedical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacogenomic (PGx) biomarkers integrated using machine learning can be embedded within the electronic health record (EHR) to provide clinicians with individualized predictions of drug treatment outcomes. Currently, however, drug alerts in the EHR are largely generic (not patient‐specific) and contribute to increased clinician stress and burnout. Improving the usability of PGx alerts is an urgent need. Therefore, this work aimed to identify principles for optimal PGx alert design through a health‐system‐wide, mixed‐methods study. Clinicians representing multiple practices and care settings ( N = 1062) in urban, rural, and underserved regions were invited to complete an electronic survey comparing the usability of three drug alerts for citalopram, as a case study. Alert 1 contained a generic warning of pharmacogenomic effects on citalopram metabolism. Alerts 2 and 3 provided patient‐specific predictions of citalopram efficacy with varying depth of information. Primary outcomes included the System's Usability Scale score (0–100 points) of each alert, the perceived impact of each alert on stress and decision‐making, and clinicians' suggestions for alert improvement. Secondary outcomes included the assessment of alert preference by clinician age, practice type, and geographic setting. Qualitative information was captured to provide context to quantitative information. The final cohort comprised 305 geographically and clinically diverse clinicians. A simplified, individualized alert (Alert 2) was perceived as beneficial for decision‐making and stress compared with a more detailed version (Alert 3) and the generic alert (Alert 1) regardless of age, practice type, or geographic setting. Findings emphasize the need for clinician‐guided design of PGx alerts in the era of digital medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Health RecordsMachine LearningCitalopramPharmacogeneticsHumansFemaleMaleAdultSurveys and QuestionnairesMiddle AgedMedical Order Entry SystemsPhysicians

Substanzen

Citalopram

Autor:innen und Institutionen

  • Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Family Medicine, Mayo Clinic, Scottsdale, Arizona, USA.
  • Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, Arizona, USA.

ORCID-Profile: Caroline W Grant, Jean Marrero-Polanco, Jeremiah B Joyce, Barbara Barry, Ashley Stillwell, Therese Anderson, Mary Hedges, Jose Valery, Richard White, Richard R Sharp, Paul E Croarkin, Liselotte N Dyrbye, William V Bobo, Arjun P Athreya

Förderung

  • National Science Foundation
  • National Institutes of Health Predoctoral T32 Fellowship
  • Harry C. and Debra A. Stonecipher Predoctoral Fellowship (CWG) at the Mayo Clinic Graduate School of Biomedical Sciences

Zitieren

APA

Grant, C. W., Marrero-Polanco, J., Joyce, J. B., Barry, B., Stillwell, A., Kruger, K., Anderson, T., Talley, H., Hedges, M., Valery, J., White, R., Sharp, R. R., Croarkin, P. E., Dyrbye, L. N., Bobo, W. V., & Athreya, A. P. (2024). Pharmacogenomic augmented machine learning in electronic health record alerts: A health system‐wide usability survey of clinicians. Clinical and Translational Science. https://doi.org/10.1111/cts.70044

Vancouver

Grant CW, Marrero-Polanco J, Joyce JB, Barry B, Stillwell A, Kruger K, et al. Pharmacogenomic augmented machine learning in electronic health record alerts: A health system‐wide usability survey of clinicians. Clinical and Translational Science. 2024. doi:10.1111/cts.70044

BibTeX
@article{Grant2024,
  author = {Grant, Caroline W and Marrero-Polanco, Jean and Joyce, Jeremiah B and Barry, Barbara and Stillwell, Ashley and Kruger, Kellie and Anderson, Therese and Talley, Heather and Hedges, Mary and Valery, Jose and White, Richard and Sharp, Richard R and Croarkin, Paul E and Dyrbye, Liselotte N and Bobo, William V and Athreya, Arjun P},
  title = {Pharmacogenomic augmented machine learning in electronic health record alerts: A health system‐wide usability survey of clinicians},
  journal = {Clinical and Translational Science},
  year = {2024},
  doi = {10.1111/cts.70044}
}
Kostenlos starten →